ALLIANCES AND COLLABORATIONS (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Alliances and Collaborations Statement [Line Items]
Net product sales	$ 2,770	$ 3,024	$ 5,577	$ 5,981
Alliance and other revenues	1,119	1,024	2,123	1,898
Total revenues	3,889	4,048	7,700	7,879
Receivables - from alliance partners	1,033		1,033		1,122
Deferred income from alliances	2,132		2,132		1,525
Written Option Liability [Member]
Alliances and Collaborations Statement [Line Items]
Fair value of the written option	198		198		162
Abilify [Member]
Alliances and Collaborations Statement [Line Items]
Alliance and other revenues	499	454	940	849
Total revenues	555	563	1,095	1,085
Eliquis [Member]
Alliances and Collaborations Statement [Line Items]
Total revenues	171	12	277	34
Otsuka [Member] | United States [Member] | Abilify [Member]
Alliances and Collaborations Statement [Line Items]
Percentage of net sales recognized from collaboration	33.00%	34.00%	33.00%	34.00%
Pfizer [Member] | Eliquis [Member]
Alliances and Collaborations Statement [Line Items]
Upfront, milestone and other licensing payments received			60
Valeant [Member]
Alliances and Collaborations Statement [Line Items]
Proceeds expected to be received from an alliance partner upon the exercise of an option to acquire the trademarks and intellectual property of certain products			60
Charge included in other expense related to the increase in the fair value of a written option			16
Valeant [Member] | Written Option Liability [Member]
Alliances and Collaborations Statement [Line Items]
Fair value of the written option	34		34
Reckitt Benckiser Group [Member]
Alliances and Collaborations Statement [Line Items]
Charge included in other expense related to the increase in the fair value of a written option			15
Reckitt Benckiser Group [Member] | Written Option Liability [Member]
Alliances and Collaborations Statement [Line Items]
Fair value of the written option	129		129
Alliance Partners [Member]
Alliances and Collaborations Statement [Line Items]
Net product sales	782	1,054	1,677	2,077
Alliance and other revenues	1,039	958	1,951	1,767
Total revenues	1,821	2,012	3,628	3,844
Payments to/(from) alliance partners - Cost of products sold	323	338	678	627
Payments to/(from) alliance partners - Marketing, selling and administrative	6	(27)	3	(69)
Payments to/(from) alliance partners - Advertising and product promotion	32	(7)	67	(22)
Payments to/(from) alliance partners - Research and development	(4)	(31)	(35)	(55)
Payments to/(from) alliance partners - Other income/expense	(158)	(100)	(553)	(172)
Net earnings attributable to noncontrolling interest, pre-tax	7	(1)	11	23
Receivables - from alliance partners	1,033		1,033		1,122
Accounts payable - to alliance partners	1,552		1,552		1,396
Deferred income from alliances	1,958		1,958		5,089
Deferred income from alliances included in liabilities related to assets held-for-sale					$ 3,671